WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Phase 2
Active, not recruiting
- Conditions
- Extensive-stage Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2020-05-04
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 11
- Registration Number
- NCT04373369
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children
Not Applicable
Completed
- Conditions
- Surgical Site Infection
- Interventions
- Other: Order set review and modificationBehavioral: Order set review and modification with facilitation
- First Posted Date
- 2020-04-28
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 39363
- Registration Number
- NCT04366440
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine / Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States
🇺🇸Harvard Medical School / Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸University of Michigan / CS Mott Children's Hospital, Ann Arbor, Michigan, United States
Systemic Absorption of Lidocaine After Hematoma Block
Phase 4
Withdrawn
- Conditions
- LidocaineHematomaPediatricsRadius Fracture Distal
- Interventions
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT04359017
- Locations
- 🇺🇸
Saint Louis Children's Hospital, Saint Louis, Missouri, United States
Evaluation of Antibody Tests for COVID-19
Completed
- Conditions
- CoronavirusCOVID
- Interventions
- Diagnostic Test: Diagnostic test
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 461
- Registration Number
- NCT04360954
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML
Phase 2
Withdrawn
- Conditions
- Refractory Acute Myeloid LeukemiaRelapsed Acute Myeloid Leukemia
- Interventions
- Biological: Cytokine induced memory-like NK cellsProcedure: Leukapheresis
- First Posted Date
- 2020-04-21
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT04354025
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
- Conditions
- Healthy VolunteerEsophageal CancerColon CancerProstate CancerHead and Neck CancerSolid Tumor CancerGenitourinary CancerSarcomaBreast CancerGastrointestinal Cancer
- First Posted Date
- 2020-04-21
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 100
- Registration Number
- NCT04354064
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Ruxolitinib to Combat COVID-19
- First Posted Date
- 2020-04-21
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT04354714
Improvisational Dance for Parkinson Disease
Not Applicable
- Conditions
- Parkinson Disease
- Interventions
- Behavioral: Improvisational Dance Class
- First Posted Date
- 2020-04-21
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT04354298
- Locations
- 🇺🇸
4444 Forest Park Ave., Saint Louis, Missouri, United States
Power of Peanuts School Feeding
Not Applicable
Completed
- Conditions
- School Feeding ProgramsNutrition Supplements
- Interventions
- Dietary Supplement: Standard mealDietary Supplement: School food ready-to-use plus MilkDietary Supplement: School food ready-to-use
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 880
- Registration Number
- NCT04349007
- Locations
- 🇬🇭
Project Peanut Butter, Tamale, Ghana
A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection
- First Posted Date
- 2020-04-13
- Last Posted Date
- 2021-07-09
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 152
- Registration Number
- NCT04342663
- Locations
- 🇺🇸
BJC, Belleville, Illinois, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath